姑息放射肿瘤学质量指标:开发与初步测试
本研究采用改良德尔菲法,由8名姑息放射肿瘤学专家和1名德尔菲方法学专家组成专家组,通过3次在线会议和2次电子邮件调查,开发了骨转移和脑转移姑息放射治疗的共7项质量指标。随后在5家机构的放射肿瘤科医生中开展试点调查,确认了这些质量指标的有效性和测量可行性。
要点
- 采用改良德尔菲法经3次在线会议和2次邮件调查达成共识。
- 开发了骨转移4项和脑转移3项姑息放射治疗质量指标。
- 2次邮件调查和2次试点调查分别确认了指标的有效性和测量可行性。
核心结论
- 开发了骨转移和脑转移姑息放射治疗的有效且可行的质量指标。
- 本研究可能有助于减少姑息放射肿瘤学中的证据与实践差距。
研究设计与样本
- 采用改良德尔菲法,专家组由8名姑息放射肿瘤学专家和1名德尔菲方法学专家组成。
- 通过在线专家组会议和电子邮件调查开发骨转移和脑转移姑息放射治疗的质量指标。
- 由5家机构的放射肿瘤科医生开展试点调查评估测量的可行性。
主要发现
- 经过3次在线会议和2次电子邮件调查,开发了骨转移4项质量指标和脑转移3项质量指标。
- 2次电子邮件调查确认了质量指标的有效性。
- 2次试点调查确认了质量指标测量的可行性。
关键数值与推荐
- 骨转移姑息放射治疗质量指标共4项。
- 脑转移姑息放射治疗质量指标共3项。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: A quality indicator (QI) is a valuable tool to evaluate the quality of health care systems. In palliative radiation oncology, only a few related QIs have been developed to date. In this study, we sought to develop and pilot test QIs that assess the quality of care in palliative radiation therapy. METHODS AND MATERIALS: A modified Delphi method was used to establish consensus with an expert panel. The panel consisted of 8 radiation oncologists who have expertise in palliative radiation oncology and 1 expert on Delphi methodology. Online panel meetings and e-mail surveys were conducted to develop QIs on palliative radiation therapy for bone and brain metastases. Feasibility of measurement was assessed though pilot surveys that were conducted by radiation oncologists at 5 facilities. RESULTS: After 3 online meetings and 2 e-mail surveys, we developed 4 QIs on bone metastases and 3 QIs on brain metastases. Two email surveys and 2 pilot surveys confirmed the validity of QIs and the feasibility of measurement, respectively. CONCLUSIONS: We developed valid and feasible QIs on palliative radiation therapy for bone and brain metastases. Our work may contribute to reduce the evidence-practice gaps in palliative radiation oncology.
引用
- Saito T, Shikama N, Takahashi T, et al. Quality Indicators in Palliative Radiation Oncology: Development and Pilot Testing. Adv Radiat Oncol. 2021. PMID: 35146217. doi:10.1016/j.adro.2021.100856
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。